1. Home
  2. NRSN vs AGAE Comparison

NRSN vs AGAE Comparison

Compare NRSN & AGAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • AGAE
  • Stock Information
  • Founded
  • NRSN 2017
  • AGAE 2017
  • Country
  • NRSN Israel
  • AGAE United States
  • Employees
  • NRSN N/A
  • AGAE N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • AGAE Cable & Other Pay Television Services
  • Sector
  • NRSN Health Care
  • AGAE Telecommunications
  • Exchange
  • NRSN Nasdaq
  • AGAE Nasdaq
  • Market Cap
  • NRSN 29.8M
  • AGAE 33.6M
  • IPO Year
  • NRSN 2021
  • AGAE N/A
  • Fundamental
  • Price
  • NRSN $1.18
  • AGAE $0.71
  • Analyst Decision
  • NRSN Buy
  • AGAE
  • Analyst Count
  • NRSN 2
  • AGAE 0
  • Target Price
  • NRSN $14.00
  • AGAE N/A
  • AVG Volume (30 Days)
  • NRSN 243.1K
  • AGAE 270.5K
  • Earning Date
  • NRSN 11-03-2025
  • AGAE 11-13-2025
  • Dividend Yield
  • NRSN N/A
  • AGAE N/A
  • EPS Growth
  • NRSN N/A
  • AGAE N/A
  • EPS
  • NRSN N/A
  • AGAE N/A
  • Revenue
  • NRSN N/A
  • AGAE $8,254,861.00
  • Revenue This Year
  • NRSN N/A
  • AGAE N/A
  • Revenue Next Year
  • NRSN N/A
  • AGAE N/A
  • P/E Ratio
  • NRSN N/A
  • AGAE N/A
  • Revenue Growth
  • NRSN N/A
  • AGAE 0.52
  • 52 Week Low
  • NRSN $0.80
  • AGAE $0.68
  • 52 Week High
  • NRSN $2.60
  • AGAE $3.79
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 44.09
  • AGAE 32.55
  • Support Level
  • NRSN $1.15
  • AGAE $0.68
  • Resistance Level
  • NRSN $1.30
  • AGAE $0.74
  • Average True Range (ATR)
  • NRSN 0.07
  • AGAE 0.06
  • MACD
  • NRSN -0.00
  • AGAE 0.01
  • Stochastic Oscillator
  • NRSN 31.43
  • AGAE 11.24

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About AGAE Allied Gaming & Entertainment Inc.

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

Share on Social Networks: